(S (NP (JJ COVID-19) (NN pandemic)) (VP (VBZ has) (VP (VBN created) (NP (NP (DT an) (JJ extreme) (NN pressure)) (PP (IN on) (NP (DT the) (JJ global) (NN healthcare) (NNS services)))))) (. .))
(S (NP (NP (ADJP (NNP Fast) (, ,) (JJ reliable) (CC and) (JJ early)) (JJ clinical) (NN assessment)) (PP (IN of) (NP (NP (DT the) (NN severity)) (PP (IN of) (NP (DT the) (NN disease)))))) (VP (MD can) (VP (VB help) (PP (IN in) (S (VP (VBG allocating) (CC and) (VBG prioritizing) (NP (NP (NNS resources)) (SBAR (S (VP (TO to) (VP (VB reduce) (NP (NN mortality)))))))))))) (. .))
(S (SBAR (IN In) (NN order) (S (VP (TO to) (VP (VB study) (NP (NP (DT the) (JJ important) (NN blood) (NNS biomarkers)) (PP (IN for) (S (VP (VBG predicting) (NP (NN disease) (NN mortality)))))))))) (, ,) (NP (DT a) (JJ retrospective) (NN study)) (VP (VBD was) (VP (VBN conducted) (PP (IN on) (NP (NP (CD 375) (ADJP (JJ COVID-19) (JJ positive)) (NNS patients)) (VP (VBN admitted) (PP (TO to) (NP (NP (NNP Tongji) (NNP Hospital)) (PRN (-LRB- -LRB-) (NP (NNP China)) (-RRB- -RRB-)))) (PP (PP (IN from) (NP (NNP January) (CD 10))) (PP (TO to) (NP (NNP February) (CD 18) (, ,) (CD 2020))))))))) (. .))
(S (NP (NP (ADJP (NNP Demographic) (CC and) (JJ clinical)) (NNS characteristics)) (, ,) (CC and) (NP (JJ patient) (NNS outcomes))) (VP (VBD were) (VP (VBN investigated) (S (VP (VBG using) (NP (NN machine) (NN learning) (NNS tools)) (S (VP (TO to) (VP (VB identify) (NP (NP (JJ key) (NNS biomarkers)) (SBAR (S (VP (TO to) (VP (VB predict) (NP (NP (DT the) (NN mortality)) (PP (IN of) (NP (JJ individual) (NN patient)))))))))))))))) (. .))
(S (NP (DT A) (NN nomogram)) (VP (VBD was) (VP (VBN developed) (PP (IN for) (S (VP (VBG predicting) (NP (NP (DT the) (NN mortality) (NN risk)) (PP (IN among) (NP (JJ COVID-19) (NNS patients))))))))) (. .))
(S (NP (NP (NNP Lactate) (NN dehydrogenase)) (, ,) (NP (NP (NNS neutrophils)) (PRN (-LRB- -LRB-) (NP (NN %)) (-RRB- -RRB-))) (, ,) (NP (NP (FW lymphocyte)) (PRN (-LRB- -LRB-) (NP (NN %)) (-RRB- -RRB-))) (, ,) (NP (JJ high) (JJ sensitive) (JJ C-reactive) (NN protein)) (, ,) (CC and) (NP (NP (NN age)) (: -) (VP (VBN acquired) (PP (IN at) (NP (JJ hospital) (NN admission)))))) (VP (VBD were) (VP (VBN identified) (PP (IN as) (NP (NP (JJ key) (NNS predictors)) (PP (IN of) (NP (NN death))))) (PP (IN by) (NP (JJ multi-tree) (NNP XGBoost) (NN model))))) (. .))
(S (NP (NP (DT The) (NN area)) (PP (IN under) (NP (NN curve))) (PRN (-LRB- -LRB-) (NP (NNP AUC)) (-RRB- -RRB-)) (PP (IN of) (NP (DT the) (NN nomogram))) (PP (IN for) (NP (DT the) (NN derivation) (CC and) (NN validation) (NN cohort)))) (VP (VBD were) (NP (NP (CD 0.961) (CC and) (CD 0.991)) (, ,) (ADVP (RB respectively)))) (. .))
(S (NP (NP (DT An) (VBN integrated) (NN score)) (PRN (-LRB- -LRB-) (NP (NNP LNLCA)) (-RRB- -RRB-))) (VP (VBD was) (VP (VBN calculated) (PP (IN with) (NP (DT the) (JJ corresponding) (NN death) (NN probability))))) (. .))
(S (NP (JJ COVID-19) (NNS patients)) (VP (VBD were) (VP (VBN divided) (PP (IN into) (NP (NP (CD three) (NNS subgroups)) (: :) (NP (NP (ADJP (JJ low-) (, ,) (JJ moderate-) (CC and) (JJ high-risk)) (NNS groups)) (VP (VBG using) (NP (NP (NNP LNLCA) (NN cut-off) (NNS values)) (PP (IN of) (NP (CD 10.4) (CC and) (CD 12.65))) (PP (IN with) (S (NP (DT the) (NN death) (NN probability)) (NP (NP (QP (JJR less) (IN than) (CD 5)) (NN %)) (, ,) (NP (QP (CD 5) (NN %) (TO to) (CD 50) (NN %))) (, ,) (CC and) (IN above) (NP (CD 50) (NN %)) (, ,) (ADVP (RB respectively)))))))))))) (. .))
(S (NP (NP (DT The) (NX (JJ prognostic) (NN model))) (, ,) (NP (JJ nomogram)) (CC and) (NX (NNP LNLCA) (NN score))) (VP (MD can) (VP (VB help) (PP (IN in) (NP (NP (JJ early) (NN detection)) (PP (IN of) (NP (NP (JJ high) (NN mortality) (NN risk)) (PP (IN of) (NP (NNP COVID-19) (NNS patients))))))) (, ,) (SBAR (WHNP (WDT which)) (S (VP (MD will) (VP (VB help) (S (NP (NNS doctors)) (VP (TO to) (VP (VB improve) (NP (NP (DT the) (NN management)) (PP (IN of) (NP (JJ patient) (NN stratification))))))))))))) (. .))
